학술논문
Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual patient data from four prospective observational studies
Document Type
Article
Author
Source
In: Breast Cancer . (Breast Cancer, January 2023, 30(1):88-100)
Subject
Language
English
ISSN
18804233
13406868
13406868